NeuroVive Pharmaceutical AB announced a change in leadership of the company. Effective September 1, 2015, Mikael Brönnegård will no longer serve as Chief Executive Officer. The Board announced that the company's COO Jan Nilsson, who has extensive experience at senior levels within international pharmaceutical companies, will take over as interim CEO.

The recruitment process to find a successor has begun and the company's COO Jan Nilsson will head up the company in the role of interim CEO in the period until a new CEO is appointed by the Board of Directors.